Use of urinary naloxone levels in a single provider practice: a case study | Addiction Science & Clinical Practice | Full Text

Use of urinary naloxone levels in a single provider practice: a case study | Addiction Science & Clinical Practice | Full Text

Use of urinary naloxone levels in a single provider practice: a case study

Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed medication directly into urine (known ...

Authors:Jill S. Warrington, Kaitlyn Booth, Gregory S. Warrington and Samuel Francis-Fath

Citation:Addiction Science & Clinical Practice 2020 15:3

Content type:Case Study

Published on: 15 January 2020

• ViewFull Text
 
• ViewPDF